chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving the Moderna COVID-19 booster shot, I lost my hearing in my left ear. I had no fever, no ear pain, no sinus pain, no throat pain. This hearing loss persisted for 2 days and I eventually went to patient care where they confirmed there was no visual inflammation in my left ear. Yet, they still prescribed me Amoxicillin-Clav 875-125mg tablets which I were to take 1 tablet by mouth every 12 hours. After a few days, I regained my hearing (around 12/8/2021). However, around 12/17/2021, I lost my hearing again in my left ear. I did not have any other symptoms. After 2 days, I regained my hearing. Most recently, I lost my hearing in my left ear on (12/24/2021). At this point, I was very concerned and scheduled an appointment with an ENT doctor. She stated that she has had many patients coming in with the same concern after receiving the COVID vaccine. This is very disturbing.
I have had a dull headache nearly constantly since receiving my 2nd shot. I am very in tune with headaches and my triggers and the constant nature of them seems abnormal. When I take zolmitriptan the headache goes away, but I am not supposed to take that everyday, nor does my prescription provide me enough to take everyday.  I have also been lethargic and unmotivated to exercise (which is very abnormal for me).
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 16-APR-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R024906 with expiration date 30-AUG-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
Rash described as chickenpox by MD after examination on 7-7-07. No fever. Diagnosis confirmed on 7-9-07, after examination by MD. On 7-10-07, approximately 167 skin lesions; still developing and spreading.
12 hours after vaccination, a really bad headache woke me up in the middle of the night.  I also had fever (normally, my body temperature is below standard) and my joints hurt me. I took acetaminophen. Next morning, after light breakfast I took more acetaminophen mixed with ibuprofen  and went to sleep. I kept alternating both medications every 4 to 6 hours and I got better in the next 36 hours.
pt recv vax;devel nodule at inject site,same day fever of 102 which lasted couple of day;used apap&sx resolved w/out intervention of MD;
11-28-05 Rash developed. 11-25-05 Fever developed on Amoxil, antibiotic change to Zithromax. 11-27-05 Phone call from mother pt has white patches on throat advised to be seen if no improvement. 11-29-05 Dx with measles vaccine reaction also with acellular ataxia at time of vaccine.
BODY ACHES; UNCOMFORTABLE; COLD; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 20-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. Batch number was not reported. The company is unable to perform follow up to request batch/lot number. On 20-MAR-2021, the subject experienced body aches. On 20-MAR-2021, the subject experienced uncomfortable. On 20-MAR-2021, the subject experienced cold. On 20-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, chills, cold, and uncomfortable. This report was non-serious.
The pharmacist discovered that the Johnson and Johnson vaccine had been left out longer that the 2 hours allowed after puncture at room temperature.  The vaccine had been out for approximately 3.5 hours after puncture.  The manufacturer was contacted, and the pharmacist was told that the literature does not state that this is a reason for revaccination.  The patient has not reported any adverse effects.
No additional AE reported; Pharmacist called to report that a patient received an expired VARIVAX on 6/8/2022.; This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, concomitant medications, pertinent medical history or drug reactions/allergies was not provided.  On 08-JUN-2022, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot # T010308, expiration date 24-MAR-2022, serial Number 102648664469 (dose, strength, route of administration, and anatomical location were not provided) administered for prophylaxis (expired product administered). No additional adverse events were reported. No further information provided.
Swollen hands and fingers with numbness and tingling. Within 20 minutes of injection, she developed face tingling and was "itching all over." Recipient worked at a doctor's office, so she was treated with IV fluids and Benadryl 50mg IV.
Difficulty sleeping on the side of left arm; Numb/ Continuous numbness; Tingling sensation/runs all the way down that arm to the fingertips/Continuous tingling; Pain in fingertips; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INSOMNIA (Difficulty sleeping on the side of left arm), HYPOAESTHESIA (Numb/ Continuous numbness), PARAESTHESIA (Tingling sensation/runs all the way down that arm to the fingertips/Continuous tingling) and PAIN IN EXTREMITY (Pain in fingertips) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Stroke. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Difficulty sleeping on the side of left arm), HYPOAESTHESIA (Numb/ Continuous numbness), PARAESTHESIA (Tingling sensation/runs all the way down that arm to the fingertips/Continuous tingling) and PAIN IN EXTREMITY (Pain in fingertips). At the time of the report, INSOMNIA (Difficulty sleeping on the side of left arm), HYPOAESTHESIA (Numb/ Continuous numbness), PARAESTHESIA (Tingling sensation/runs all the way down that arm to the fingertips/Continuous tingling) and PAIN IN EXTREMITY (Pain in fingertips) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Light headedness-still experiencing 3 days letter,  fatigue-2 days later, arm sore for the next day, headache.
This is in follow-up to report(s) previously submitted on 7/15/2008. Information has been received from a nurse practitioner concerning a 20 year old female, weight 115lb, with no relevant medical history or allergies who on 07-APR-2008 was vaccinated with a first dose of GARDASIL vaccine by intramuscular injection (lot number 659964/1978U) in deltoid. There was no concomitant medication. About one hour post vaccination, the patient developed swollen neck glands and a sore throat. The patient sought medical attention with a telephone call. The symptoms lasted for 3-4 days and then self resolved. Additional information is not expected.
Pt called the pharmacy the next day after the vaccines and stated that she felt "paralyzed temporarily".  She said it only lasted a little while. Suggested pt stop REGLAN and call dr ASAP.
w/in an hr p/vax pt began to scream;screamed for 2 1/2-3hr was observed in this clinic then sent to local ER;stopped crying by the time MD saw so not tx given;slept well that noc & next day had no sx;
left ring finder tender on Monday 03/22/21,  Woke up Tuesday, 03/23/21 finger swollen, as the day has gone on it has gotten redder Called and spoke with a Teladoc doctor, said to take ibuprofen and ice, watch for 24/48 hours if gets redder or hot go and have it checked out for possible infection
Expired dose administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 57-year-old female patient who received HAB (Twinrix) (batch number DK23D, expiry date 8th February 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 16th February 2022, the patient received the 1st dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 16th February 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient inadvertently received an expired dose of Twinrix, which led to expired vaccine used. The reporter consented to follow up.
has not received the second vaccination; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 83-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose in January 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: has not received the second vaccination). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 20-Oct-2023 Consumer called on the day of reporting and reported he had not received the second vaccination. The reporter consented to follow-up. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.
strange taste in mouth / tasting sauteed green onions and green peppers; smelling and tasting sauteed green onions and green peppers; voice a little hoarse; chest hurts when taking a deep breath; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EP6955), via an unspecified route of administration, administered on right arm (reported as right upper arm) on 25Mar2021 at 13:00 (age at vaccination was 53-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included ongoing optic neuritis (had for 7 years; in both eyes), ongoing thyroid problems (had probably 20 years or so), ongoing gastrointestinal problems, gall bladder issues, migraine and allergies. The patient's concomitant medications included ongoing fluoxetine 20 mg capsule, latanoprost eye drops, levothyroxine sodium 75 mg for thyroid, ongoing pantoprazole sodium 40 mg tablet, ongoing valproic acid 250 mg capsule for migraine and an over the counter medicine for allergies. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. On 26Mar2021, the patient experienced strange taste in mouth; smelling and tasting sauteed green onions and green peppers; voice a little hoarse and chest hurts when taking a deep breath. It was further reported that the strange taste in her mouth started day after the vaccine and slowly started to linger away or dwindle. The patient was smelling and tasting sauteed green onions and green peppers and it was out of the blue when it came but was slowly disappearing. It was reported that her voice has been a little hoarse and was still the same until the report. Her chest hurts when she takes a deep breath in sometimes, she describe it like the feeling you get when you are out in the cold and it hurts; and was still the same until the report. The patient wants to know if there was a certain time to wait for the symptoms and if she should go to see her doctor. No therapeutic measures taken as a result of the events. The outcome of the events strange taste in mouth; and smelling and tasting sauteed green onions and green peppers were recovering while other reported events were not recovered.  No follow-up attempts are possible. No further information is expected.
Patient reported: "I have developed a pretty large area of redness, mild swelling and very warm area on my left arm below injection site. It is mildly itchy and sore."
Approximately 3-5 minutes after administration of Bivalent moderna COVID shot and Fluad high dose flu shot, patient reported difficulty breathing. EMS was contacted and requested to respond and epinephrine auto-inj 0.3 mg/0.3 mL was administered to right thigh of patient who was showing slight signs of cyanosis and extremely labored breathing. Approximately 2-3 minutes after epinephrine administration patient showed signs of breathing improvement and was provided with an albuterol rescue inhaler which patient was able to adequately inhale 1 dose of. Approximately 5-7 minutes after contacting EMS, two EMTs arrived and assessed the patient, who was then advised to present to ER for further follow-up and monitoring.
Pain, swelling, bumpy and red rash, pain moved to arm pit- lymph node- enough to keep from sleeping. Symptoms progressed over several hours. Still monitoring
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2022 at 2:17 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 01-Apr-2022 at 2:17 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 01-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter. Treatment information was not provided. Patient took the second booster dose on 01-Apr-2022 at 14:17:07
swollen lymph nodes under his right armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes under his right armpit) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.  No Medical History information was reported.  On 14-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes under his right armpit). The patient was treated with PREDNISONE for Swollen lymph nodes, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (swollen lymph nodes under his right armpit) had resolved.  Concomitant medication of the patient was not reported.  A few days later, the patient experienced the adverse event. The event lasted about a week to 10 days.  The patient also received antihistamine as corrective treatment.   This case was linked to MOD-2022-464106, MOD-2022-464124 (Patient Link).
Multiple red lines started appearing on her neck on both sides, and 2 red lines on her face but no discomfort or itchiness. Subsided within a few minutes and almost disappeared.
Arm swelling started shortly after flu vaccine given.  Patient was then diagnosed with R brachial DVT and pulmonary embolism after presenting to ER 13 October 2016.
Extreme fatigue; Flu-like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 13May2021 at 09:30 (at the age of 17-years-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food or other products. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 10:45, the patient experienced extreme fatigue and flu-like symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events extreme fatigue and flu-like symptoms were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
febrile seizure (first one) within 12 hours of vaccine with no intercurrent illness and complete resolution within 12 hours...no further fever
Patient was sitting in chair after receiving vaccination. Patient leaned down to put her vaccination card into her purse. Upon leaning over, patient fell off side of chair. Chair was stationary and did not have side rails on it. Nurse witness called facilitator over to perform assessment. Patient denies injury. Reports falling onto her left wrist. Patient moving wrist without difficulty. No redness, swelling, or deformity noted upon nursing assessment. Patient denies pain. Cap refill brisk. Patient denies need for further assessment by ED at this time. Patient declined ice pack. Patient denies dizziness at time of fall.